1]. R. Eccles, M. Eriksson, S. Garreffa, S. Chen, American journal of rhinology, 22, 491-496, (2008).
[2]. R. Ahmadi, et al., Journal of Bio-Inorganic Hybrid Nanomaterials. 4, 249-254, (2015).
[3]. Z. Zhou, Pharmaceutics, 5, 525, (2013).
[4]. P. Anilkumar, F. Lu, L. Cao, P. G. Luo, J. H. Liu, S. Sahu, K. N. Tackett, Y. Wang, Y. P. Sun, Current Medicinal Chemistry, 18(14), 2045, (2011).
[5]. K. Chris K. “Fullurenes in medicine, will it ever occur?” Journal of Nanomedicine & Nanotechnology, 2012.
[6]. R. Ahmadi, Journal of physical chemistry and Theoretical Chemistry, 3, 185-190, (2012).
[7]. S. V. shetab boushehri, et al., Acta Medica Iranica, 48, 5, (2010).
[8]. L. J. Wilson, The Electrochemical Society Interface., 84, (1999).
[9]. D. Franskevych S. Prylutska I. Grynyuk D. Grebinyk O. Matyshevska Experimental oncology, 187-191, (2015).
[10]. S. Prylutska, I. Grynyuk, O. Matyshevska, Y. Prylutskyy, M. Evstigneev, P. , Drugs in R & D, 2014; 14, 333-340, (2014).
[11]. A.Hirsch, M.Brettreich, Fullerenes: Chemistry and Reactions, Willey VCH. Verlag GmbH, 2005.
[12]. شیمی کوانتوم، قاسم خدادادی، انتشارات دانشگاه پیام نور، چاپ سوم، خرداد ۱۳۸۵.
[13]. Y. Yunxiaoliang, et. al., THEOCHEM, 765, 1-11, (2006).
[14]. E. Sorensen, J. Bioorg. Med. Chem., 11, 3225-3228, (2003).
[15]. M. Schmid, J. Donges, Th. Hippler, H. Haberland, Phys. Rev. Lett., 90, 103401-103406, (2003).
[16] M. J. Frisch, et. al., GAUSSIAN 09, Revision A.1, GAUSSIAN Inc,. Wallingford, CT., (2009).
[17] S. Geerlings, F. De Proft, W. Langenaeker, Chem. Rev., 103, 1793-1874, (2003).
[18]. E. Sorensen, J. Bioorg. Med. Chem., 11, 3225-3228, (2003).
[19]. M. Schmid, J. Donges, T. H. Hippler, H. Haberland, Phys. Rev. Lett., 90, 103401-103406, (2003).
[20] R. G. Parr, L. V. Szentpaly, S. Liu, J. Am. Chem. Soc., 121, 1922–1924, (1999).
[21] R. Ahmadi, R. Solymani, S. T. Yousofzad, C. Structure., 100, 60, (2012).
)
